Inhaled corticosteroids, bone mineral density and fracture in older people

Drugs and Aging

Volumn 21, Issue 10, 2004, Pages 631-638

  Hubbard, Richard ^a   Tattersfield, Anne ^a  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BECLOMETASONE; BUDESONIDE; CORTICOSTEROID; PREDNISOLONE; TRIAMCINOLONE;

ADRENAL CORTEX INSUFFICIENCY; ALLERGIC RHINITIS; ASTHMA; BONE DENSITY; BONE METABOLISM; BONE MINERAL; CAPILLARY RESISTANCE; CATARACT; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL TRIAL; DISEASE COURSE; DOSE RESPONSE; DRUG HYPERSENSITIVITY; DRUG POTENCY; ECZEMA; FRACTURE; HUMAN; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; INTRAOCULAR HYPERTENSION; LUMBAR SPINE; LUNG FUNCTION; OPEN ANGLE GLAUCOMA; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; RISK BENEFIT ANALYSIS; SIDE EFFECT; SYSTEMIC CIRCULATION;

ADMINISTRATION, INHALATION; ADRENAL CORTEX HORMONES; AGING; BONE DENSITY; CASE-CONTROL STUDIES; COHORT STUDIES; DOSE-RESPONSE RELATIONSHIP, DRUG; FRACTURES, BONE; HUMANS; META-ANALYSIS;

EID: 4344561296     PISSN: 1170229X     EISSN: None     Source Type: Journal    
DOI: 10.2165/00002512-200421100-00002     Document Type: Review

References (63)

1. Brown HM, Storey G, George WH. Beclomethasone dipropionate: a new steroid aerosol for the treatment of allergic asthma. BMJ 1972; I: 585-90
2. Clark TJH. Effect of beclomethasone dipropionate delivered by aerosol in patients with asthma. Lancet 1972; I: 1361-4
3. British Thoracic and Tuberculosis Association. Inhaled corticosteroids compared with oral prednisolone in patients starting long term corticosteroid therapy for asthma. Lancet 1975; II: 469-73
4. Maberly DJ, Gibson GJ, Butler AG. Recovery of adrenal function after substitution of beclomethasone dipropionate for oral corticosteroids. BMJ 1973; I: 778-82
5. Haahtela T, Jarvinen M, Kava T, et al. Comparison of beta-2 agonist terbutaline with an inhaled corticosteroid budesonide in newly detected asthma. N Engl J Med 1991; 325: 338-92
6. Pauwels R, Lofdahl C-G, Postma DS, et al. Effect of inhaled formoterol and budesonide on exacerbations of asthma. N Engl J Med 1997; 337: 1405-11
7. Pauwels R, Pedersen S, Busse WW, et al. Early intervention with budesonide in mild persistent asthma: a randomised, double-blind trial. Lancet 2003; 361: 1071-6
8. Janson C, Chinn S, Jarvis D, et al. Physician diagnosed asthma and drug utilisation in the European Community Respiratory Health Survey. Eur Respir J 1997; 10: 1795-802
9. Roberts SJ, Bateman DN. Which patients are prescribed inhaled anti-asthma drugs? Thorax 1994; 49: 1090-5
10. Burge PS, Calverley PM, Jones PW, et al. Randomised, double blind, placebo controlled study of fluticasone propionate in patients with moderate to severe chronic obstructive pulmonary disease: the ISOLDE trial. BMJ 2000; 320: 1297-303
11. Pauwels R, Lofdahl C-G, Laitinen LA, et al. Long-term treatment with inhaled budesonide in persons with mild chronic obstructive pulmonary disease who continue to smoke. N Engl J Med 1999; 340: 1948-53
12. The Lung Health Study Research Group. Effect of inhaled triamcinolone on the decline in pulmonary function in chronic obstructive pulmonary disease. N Engl J Med 2000; 343: 1902-9
13. Vestbo J, Sorensen T, Lange P, et al. Long-term effect of inhaled budesonide in mild and moderate chronic obstructive pulmonary disease: a randomised controlled trial. Lancet 1999; 353: 1819-23
14. Donnelly R, Williams KM, Baker AB, et al. Effects of budesonide and fluticasone on 24-hour plasma cortisol. Am J Respir Crit Care Med 1997; 156: 1746-51
15. Kerrebijn KF. Use of topical corticesteroids in the treatment of childhood asthma. Am Rev Respir Dis 1990; 141: S77-81
16. Toogood JH, Lefcoe MS, Haines DSM, et al. A graded dose assessment of the efficacy of beclomethasone dipropionate aerosol for severe chronic asthma. J Allergy Clin Immunol 1997; 59: 298-308
17. Bisgaard H, Nielsen MD, Anderssen B, et al. Adrenal function in children with bronchial asthma treated with beclomethasone dipropionate or budesonide. J Allergy Clin Immunol 1988; 81: 1088-95
18. Jennings BH, Andersson KE, Johansson SA. Assessment of systemic effects of inhaled corticosteroids: comparison of the effects of inhaled budesonide and oral prednisolone on adrenal function and markers of bone turnover. Eur J Clin Pharmacol 1990; 40: 77-82
19. Toogood JH, Baskerville JC, Jennings B, et al. Bioequivalent doses of budesonide and prednisolone in moderate and severe asthma. J Allergy Clin Immunol 1989; 84: 688-700
20. Harrison TW, Wisniewski A, Honour J, et al. Comparison of the systemic effects of fluticasone propionate and budesonide given by dry powder inhaler in healthy and asthmatic subjects. Thorax 2001; 56: 186-91
21. Boorsma M, Andersson N, Larsson P, et al. Assessment of the relative systemic potency of inhaled fluticasone and budesonide. Eur Respir J 1996; 9: 1427-32
22. Harrison TW. Systemic availability of inhaled budesonide and fluticasone propionate: healthy versus asthmatic lungs. Biodrugs 2001; 15: 405-11
23. Todd GR, Acerini CL, Buck JJ, et al. Acute adrenal crisis in asthmatics treated with high-dose fluticasone dipropionate. Eur Respir J 2002; 19: 1207-9
24. Todd GR, Acerini CL, Ross-Russell R, et al. Survey of adrenal crisis associated with inhaled corticosteroids in the United Kingdom. Arch Dis Child 2002; 87: 457-61
25. Cumming RG, Mitchell P, Leeder SR. Use of inhaled corticosteroids and risk of cataracts. N Engl J Med 1997; 337: 8-14
26. Smeeth L, Boulis M, Hubbard R, et al. A population based case-control study of cataract and inhaled corticosteroids. Br J Ophthamol 2003; 87 (10): 1247-51
27. Garbe E, Lelorier J, Boivin J-F, et al. Inhaled and nasal glucocorticoids and the risks of ocular hypertension or open-angle glaucoma. JAMA 1997; 277: 722-7
28. Jennings BH, Andersson KE, Johansson SA. Assessment of systemic effects of inhaled glucocorticosteroids: comparison of the effects of inhaled budesonide and oral prednisolone in adrenal function and markers of bone turnover. Eur J Clin Pharmacol 1991; 40: 77-82
29. Toogood JH, Jennings B, Hodsman AB, et al. Effects of dose and dosing schedule of inhaled budesonide on bone turnover. J Allergy Clin Immunol 1991; 88: 572-80
30. Pouw EM, Prummell MF, Oosting H, et al. Beclomethasone inhalation decreases serum osteocalcin concentrations. BMJ 1991; 302: 627-8
31. Meeran K, Hattersley A, Burrin J, et al. Oral and inhaled corticosteroids reduce bone formation as shown by plasma osteocalcin levels. Am J Respir Crit Care Med 1995; 151: 333-6
32. Ali NJ, Capewell S, Ward MJ. Bone turnover during high dose inhaled corticosteroid treatment. Thorax 1991; 46: 160-4
33. Birkebaek NH, Esberg G, Andersen K, et al. Bone and collagen turnover during treatment with inhaled dry powder budesonide and beclomethasone dipropionate. Arch Dis Child 1995; 73: 524-7
34. Kerstjen HAM, Postma DS, van Doormaal JJ, et al. Effects of short term and long term treatment with inhaled corticosteroids on bone metabolism in patients with airflow obstruction. Thorax 1994; 49: 652-6
35. Jones A, Fay JK, Burr M, et al. Inhaled corticosteroid effects on bone metabolism in asthma and mild chronic obstructive pulmonary disease (Cochrane Review). Available in The Cochrane Library [database on disk and CD ROM]. Updated quarterly. The Cochrane Collaboration; issue 4. Oxford: Update Software, 2003
36. Hanania NA, Chapman KR, Sturtridge WC, et al. Dose-related decrease in bone mineral density among asthmatic patients treated with inhaled corticosteroids. J Allergy Clin Immunol 1995; 96: 571-9
37. Marystone JF, Barrett-Connor EL, Morton DJ. Inhaled and oral corticosteroids: their effect on bone mineral density in older adults. Am J Public Health 1995; 85: 1693-5
38. Laatikainen AK, Kroger HPJ, Tukiainen HO, et al. Bone mineral density in perimenopausal women with asthma. Am J Respir Crit Care Med 1999; 159: 1179-85
39. Ip M, Lam K, Yam L, et al. Decreased bone mineral density in premenopausal asthmatic patients receiving long term inhaled steroids. Chest 1994; 105: 1722-7
40. Wisniewski AF, Lewis SA, Green DJ, et al. Cross sectional investigation of the effects of inhaled corticosteroids on bone mineral density and bone metabolism in patients with asthma. Thorax 1997; 52: 853-60
41. Toogood JH, Baskerville JC, Markov AE, et al. Bone mineral density and the risk of fracture in patients receiving long term inhaled steroid therapy for asthma. J Allergy Clin Immunol 1995; 96: 157-66
42. Harris M, Hauser S, Nguyen TV, et al. Bone mineral density in prepubertal asthmatics receiving corticosteroid treatment. J Paediatr Child Health 2001; 37: 67-71
43. Lau ECM, Li M, Woo J, et al. Bone mineral density and body composition in patients with airflow obstruction: the role of inhaled steroid therapy, disease and lifestyle. Clin Exp Allergy 1998; 28: 1066-71
44. Packe GE, Robb O, Robins SP, et al. Bone density in asthmatic patients taking inhaled corticosteroids: comparison of budesonide and beclomethasone dipropionate. J R Coll Physicians Lond 1996; 30: 128-32
45. Packe GE, Douglas JG, McDonald AF, et al. Bone density in asthmatic patients taking high dose inhaled beclomethasone dipropionate and intermittent systemic corticosteroids. Thorax 1992; 47: 414-7
46. Elmstahl S, Ekstrom H, Galvard H, et al. Is there an association between inhaled corticosteroids and bone density in postmenopausal women? J Allergy Clin Immunol 2003; 111: 91-6
47. Reilly SM, Hambleton G, Adams JE, et al. Bone density in asthmatic children treated with inhaled corticosteroids. Arch Dis Child 2001; 84: 183-4
48. Kinberg KA, Hopp RJ, Biven RE, et al. Bone mineral density in normal and asthmatic children. J Allergy Clin Immunol 1994; 94: 490-7
49. Wolff AH, Adelsberg B, Aloia J, et al. Effect of inhaled corticosteroid on bone density in asthmatic patients: a pilot study. Ann Allergy 1991; 67: 117-21
50. Herrala J, Puolijoki H, Impivaara O, et al. Bone mineral density in asthmatic women on high dose inhaled beclomethasone dipropionate. Bone 1994; 15: 621-3
51. Boulet L-P, Giguere M-C, Milot J, et al. Effects of long term use of high-dose inhaled steroids on bone density and calcium metabolism. J Allergy Clin Immunol 1994; 94: 796-803
52. Wong CA, Walsh LJ, Smith CJ, et al. Inhaled corticosteroid use and bone mineral density in patients with asthma. Lancet 2000; 355: 1399-403
53. Israel E, Banerjee TR, Fitzmaurice GM, et al. Effects of inhaled glucocorticoids on bone density in premenopausal women. N Engl J Med 2001; 345: 941-7
54. Tattersfield AE, Town GI, Johnell O, et al. Bone mineral density in subjects with mild asthma randomised to treatment with inhaled corticosteroids or non-corticosteroid treatment for two years. Thorax 2001; 56: 272-8
55. Doull IJM, Freezer NJ, Holgate ST. Growth of prepubertal children with mild asthma treated with inhaled beclomethasone dipropionate. Am J Respir Crit Care Med 1995; 151: 1715-9
56. Agertoft L, Pedersen S. Effect of long-term treatment with inhaled budesonide on adult height in children with asthma. N Engl J Med 2000; 343: 1064-9
57. van Staa TP, Leufkens HGM, Abenhaim L, et al. Oral corticosteroids and fracture risk: relationship to daily and cumulative doses. Rheumatology 2000. 39 (12): 1383-9
58. Baltzan MA, Suissa S, Bauer DC, et al. Hip fractures attributable to corticosteroid use [letter]. Lancet 1999; 353: 1327
59. McEvoy CE, Ensrud KE, Bender E, et al. Association between corticosteroid use and vertebral fractures in older men with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1998; 157: 704-9
60. Walley T, Mantgani A. The UK general practice research database. Lancet 1997; 350: 1097-9
61. Hubbard RB, Smith CJP, Smeeth L, et al. Inhaled corticosteroids and fracture: a population based case-control study. Am J Respir Crit Care Med 2002; 166: 1563-6
62. van Staa TP, Leufkens HGM, Cooper C. Use of inhaled corticosteroids and risk of fractures. J Bone Miner Res 2001; 16: 581-8
63. Suissa S, Baltzan M, Kremer R, et al. Inhaled and nasal corticosteroid use and the risk of fracture. Am J Respir Crit Care Med 2004; 169: 83-8